Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE

被引:9
|
作者
Nakamuta, Makoto [1 ]
Kotoh, Kazuhiro [1 ]
Enjoji, Munechika [1 ]
Nawata, Hajime [1 ]
机构
[1] Kyushu Univ, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
Hepatocyte; Fibril-collagen; Fixed collagen;
D O I
10.3748/wjg.v11.i15.2264
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are central to the spontaneous resolution of liver fibrosis. The mechanisms involved have been investigated in hepatic stellate cells (HSC), but not in hepatocytes. We investigated the effects of fibril-and fixed-collagen on MMP-1 and TIMP-1 production in hepatocytes, using the HLE cell line. METHODS: Fibril type I and IV collagen were prepared by HCl digestion of type I and IV collagen, respectively. For fixed-collagen, culture dishes were coated with fibril type I or IV collagen and fixed by ultraviolet. Type I collagenase activity was measured using fluorescein isothiocyanate-labeled type I collagen. MMP-1 and TIMP-1 in HLE cells were measured by a one-step sandwich enzyme immunoassay. RESULTS: Both fibril type I and IV collagen significantly increased type I collagenase activity about two-fold compared with no fibril collagen. The effects of the fibril collagen were not affected by the coating condition. There was no significant difference in the effects on collagenase activity between cells cultured in medium containing fibril type I collagen and those cultured in the presence of type IV collagen. Both types of fibril collagen significantly increased MMP-1 production, and showed more than 10-fold higher levels of MMP-1 than the control. The enhanced MMP-1 production by fibril collagens was unaffected by the coating condition. By contrast, TIMP-1 production was not changed by the addition of fibril type I or IV collagen, and neither was it affected by the coating conditions. Coating with type I collagen significantly suppressed MMP-1 production by almost one-tenth compared with no coating. By contrast, TIMP-1 production was not affected by either the absence of a collagen coat or by increasing the concentration of the coating collagen. CONCLUSION: These results indicated that, in HLE cells, fibril-and fixed-collagen have opposite effects on MMP-1 production without affecting TIMP production. Fibril collagen induced collagenase activity by up-regulation of MMP-1 production without affecting TIMP-1 production. By contrast, fixed collagen reduced MMP-1 production. Our results suggest that hepatocytes might also play an important role in the regulation of the hepatic fibrosis alongside HSC. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:2264 / 2268
页数:5
相关论文
共 50 条
  • [21] Tissue inhibitor of matrix metalloproteinase-1: mediator of neuroinflammation?
    Althoff, Gioia
    Humar, Dea
    Pagenstecher, Axel
    NEURON GLIA BIOLOGY, 2007, 2 : S97 - S97
  • [22] Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer
    Kemik, Ozgur
    Kemik, Ahu Sarbay
    Sumer, Aziz
    Dulger, Ahmet Cumhur
    Adas, Mine
    Begenik, Huseyin
    Hasirci, Ismail
    Yilmaz, Ozkan
    Purisa, Sevim
    Kisli, Erol
    Tuzun, Sefa
    Kotan, Cetin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (16) : 2109 - 2112
  • [23] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [24] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [25] Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human vascular smooth muscle cells
    Kato, S
    Yasukawa, H
    Fujii, T
    Yamaguchi, M
    Miyagi, N
    Okamoto, K
    Wada, Y
    Miyamoto, T
    Morimatsu, M
    Fox, JC
    CONNECTIVE TISSUE RESEARCH, 2000, 41 (02) : 143 - 153
  • [26] Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
    Hashimoto, K
    Kihira, Y
    Matuo, Y
    Usui, T
    JOURNAL OF UROLOGY, 1998, 160 (05): : 1872 - 1876
  • [27] Glomerular Protein Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 Are Lower in Diabetic Subjects
    Cornish, Toby C.
    Bagnasco, Serena M.
    Macgregor, Anne M.
    Lu, Jie
    Selvin, Elizabeth
    Halushka, Marc K.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2009, 57 (11) : 995 - 1001
  • [28] Dose rate-dependent upregulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 by ultraviolet A in human keratinocytes
    Whiteside, J.
    Ridley, A.
    McMillan, T. J.
    Allinson, S.
    Long, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 : 43 - 43
  • [29] Concentration of matrix metalloproteinase-1, tissue inhibitor of matrix metalloproteinase-1 and its complex in peritoneal fluid in patients with endometriosis.
    Gogacz, M
    Kotarski, J
    Skorupski, P
    Jakowicki, J
    Rechberger, T
    FERTILITY AND STERILITY, 2002, 77 (02) : S46 - S46
  • [30] Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma
    Inoue, H
    Mimori, K
    Shiraishi, T
    Kataoka, A
    Sadanaga, N
    Ueo, H
    Barnard, GF
    Mori, M
    ONCOLOGY REPORTS, 2000, 7 (04) : 871 - 874